Ampio Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $161K, a 66.6% decline year-over-year.
  • Ampio Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $942K, a 84.3% decline year-over-year.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $942K, a 84.3% decline from 2022.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $5.98M, a 71.1% increase from 2021.
  • Ampio Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $3.5M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $942K $161K -$321K -66.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $1.26M $171K -$1.08M -86.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.34M $189K -$2.73M -93.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $5.07M $421K -$913K -68.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $5.98M $482K -$2.52M -84% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $8.5M $1.25M +$1.02M +459% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $7.48M $2.92M +$2.8M +2394% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.68M $1.33M +$1.18M +778% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $3.5M $3M +$3.71M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$213K $223K +$289K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$502K $117K +$248K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$750K $152K -$690K -81.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$60K -$705K -$6.83M -112% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $6.77M -$66K +$1.98M +96.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.79M -$131K -$4.13M -103% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $8.92M $842K +$3.98M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $4.95M $6.13M +$2.06M +50.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $2.88M -$2.05M -$9.79M -126% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $12.7M $4M -$3.75M -48.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $16.4M -$3.14M -$28.8M -112% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $45.2M $4.06M +$42.4M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $2.79M $7.74M +$8.89M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$6.1M $7.75M +$5.67M +272% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$11.8M $25.6M +$24.5M +2231% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$36.3M -$38.3M -$37.9M -9333% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-06
Q3 2017 $1.63M -$1.15M -$498K -76.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.13M $2.08M +$2.77M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$640K $1.1M +$1.44M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$2.08M -$406K -$411K -9652% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$1.67M -$648K -$647K -49814% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$1.02M -$684K -$697K -5609% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$327K -$342K -$387K -870% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 $59.9K $4.25K -$122K -96.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $182K -$1.3K -$6.85K -123% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $189K $12.4K +$4.92K +65.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $184K $44.5K +$41K +1173% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $143K $126K +$122K +2799% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $20.9K $5.55K +$256K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$235K $7.51K +$144K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$379K $3.5K +$126K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$505K $4.36K -$75.6K -94.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 -$429K -$250K -$467K -216% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $38.4K -$136K +$93.4K +40.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$55K -$122K -$283K -176% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $228K $79.9K -$284K -78.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $512K $217K -$59.9K -21.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $572K -$230K +$1.01M +81.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$440K $161K +$6.7M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 -$7.14M $364K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-14
Q3 2011 $277K +$287K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$1.24M -$1.24M -41902% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$6.54M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$10.5K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 -$2.96K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.